Alexander Menter

434 total citations
7 papers, 122 citations indexed

About

Alexander Menter is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Alexander Menter has authored 7 papers receiving a total of 122 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Pulmonary and Respiratory Medicine and 2 papers in Genetics. Recurrent topics in Alexander Menter's work include Chronic Lymphocytic Leukemia Research (2 papers), Immunodeficiency and Autoimmune Disorders (2 papers) and Cancer therapeutics and mechanisms (1 paper). Alexander Menter is often cited by papers focused on Chronic Lymphocytic Leukemia Research (2 papers), Immunodeficiency and Autoimmune Disorders (2 papers) and Cancer therapeutics and mechanisms (1 paper). Alexander Menter collaborates with scholars based in United States, Ireland and Canada. Alexander Menter's co-authors include Andrea J. Cohen, Maureen O’Keeffe‐Rosetti, Deborah Schrag, Jennifer R. Brown, Ian W. Flinn, Carolyn Owen, Erin J. Aiello Bowles, Nina D. Wagner‐Johnston, Anna N.A. Tosteson and Hajime Uno and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Integrative Cancer Therapies.

In The Last Decade

Alexander Menter

7 papers receiving 119 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alexander Menter United States	5	40	34	32	27	19	7	122
K. M. Steve Lo United States	4	50 1.3×	69 2.0×	9 0.3×	159 5.9×	18 0.9×	7	303
Walter Smalley United States	3	11 0.3×	61 1.8×	6 0.2×	32 1.2×	28 1.5×	4	329
Yuanmei Gao China	7	11 0.3×	36 1.1×	5 0.2×	18 0.7×	61 3.2×	17	248
Bao Li China	7	26 0.7×	10 0.3×	2 0.1×	13 0.5×	9 0.5×	21	170
Richard Viskochil United States	8	27 0.7×	51 1.5×	2 0.1×	14 0.5×	14 0.7×	16	195
Daniela Paepke Germany	9	94 2.4×	47 1.4×		28 1.0×	7 0.4×	35	247
Jeremias Antinew United States	6	6 0.1×	19 0.6×	9 0.3×	18 0.7×		11	339
Diljit Kaur‐Knudsen Denmark	8	3 0.1×	21 0.6×	3 0.1×	11 0.4×	38 2.0×	13	181
Serdal Aktolga Türkiye	3	3 0.1×	67 2.0×	5 0.2×	11 0.4×	71 3.7×	3	173
Ji Soo Lee South Korea	7	3 0.1×	10 0.3×	3 0.1×	24 0.9×	5 0.3×	9	141

Countries citing papers authored by Alexander Menter

Since Specialization

Citations

This map shows the geographic impact of Alexander Menter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander Menter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander Menter more than expected).

Fields of papers citing papers by Alexander Menter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander Menter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander Menter. The network helps show where Alexander Menter may publish in the future.

Co-authorship network of co-authors of Alexander Menter

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander Menter. A scholar is included among the top collaborators of Alexander Menter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander Menter. Alexander Menter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

Tsui, David Chun Cheong, Dara L. Aisner, Hala Nijmeh, et al.. (2021). Tumor Shrinkage With Combination of Alectinib and Trastuzumab in a Patient With ALK-Rearranged Non–small Cell Lung Cancer Harboring HER2-Amplification as an Acquired Resistance Mechanism to ALK Inhibitor Therapy. Clinical Lung Cancer. 23(2). e99–e103. 4 indexed citations

Brooks, Gabriel A., Hajime Uno, Erin J. Aiello Bowles, et al.. (2019). Hospitalization Risk During Chemotherapy for Advanced Cancer: Development and Validation of Risk Stratification Models Using Real-World Data. JCO Clinical Cancer Informatics. 3(3). 1–10. 17 indexed citations

Jones, Jeffrey A., Tadeusz Robak, Małgorzata Wach, et al.. (2016). Updated results of a phase III randomized, controlled study of idelalisib in combination with ofatumumab for previously treated chronic lymphocytic leukemia (CLL).. Journal of Clinical Oncology. 34(15_suppl). 7515–7515. 13 indexed citations

Jones, Jeffrey A., Małgorzata Wach, Tadeusz Robak, et al.. (2015). Results of a phase III randomized, controlled study evaluating the efficacy and safety of idelalisib (IDELA) in combination with ofatumumab (OFA) for previously treated chronic lymphocytic leukemia (CLL).. Journal of Clinical Oncology. 33(15_suppl). 7023–7023. 19 indexed citations

Menter, Alexander, Virginia F. Borges, Rachel Rabinovitch, et al.. (2006). A woman with primary breast cancer and a solitary sternal metastasis.. PubMed. 20(9). 1068–71, 1075, 1079. 1 indexed citations

Cohen, Andrea J., et al.. (2005). Acupuncture: Role in Comprehensive Cancer Care—A Primer for the Oncologist and Review of the Literature. Integrative Cancer Therapies. 4(2). 131–143. 46 indexed citations

Witta, Samir E., Daniel L. Gustafson, A. Scott Pierson, et al.. (2004). A Phase I and Pharmacokinetic Study of Exisulind and Docetaxel in Patients with Advanced Solid Tumors. Clinical Cancer Research. 10(21). 7229–7237. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact